Oral Psoriasis Treatment Adherence and Intervention Study
Sponsor: Pfizer
This NA trial investigates Psoriasis and is currently completed. Pfizer leads this study, which shows 28 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
28 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2024 — Jul 2024 [monthly]
Completed NA
-
Oct 2023 — Jan 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2023 — Oct 2023 [monthly]
Active Not Recruiting NA
▶ Show 23 earlier versions
-
Aug 2023 — Sep 2023 [monthly]
Active Not Recruiting NA
-
May 2023 — Aug 2023 [monthly]
Active Not Recruiting NA
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting NA
-
Jan 2023 — Apr 2023 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Jan 2023 [monthly]
Active Not Recruiting NA
-
Feb 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
-
Dec 2021 — Feb 2022 [monthly]
Active Not Recruiting NA
-
Sep 2021 — Dec 2021 [monthly]
Active Not Recruiting NA
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jul 2020 — Nov 2020 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Jul 2020 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
-
Sep 2019 — Nov 2019 [monthly]
Active Not Recruiting NA
-
Jan 2019 — Sep 2019 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Jan 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Recruiting NA
Phase: PHASE3 → NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE3
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Feb 2017 — Dec 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .